Theriva Biologics TOVX
NYSE TOVX
$0.19 +0.00 (+1.21%)
As of: Oct 23, 2026 · 3:24 PM EDT

Theriva Biologics (TOVX) Cash from Discontinued Operations (2011 - 2012)

Updated

Analysis

Theriva Biologics (TOVX) Cash from Discontinued Operations (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Theriva Biologics 8.83 Mn -37.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 -649,000.00
Mar 31, 2011 -37,000.00
API Access

Theriva Biologics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=TOVX&period=max&api_key=YOUR_API_KEY